Karolina Okła

1.8k total citations · 1 hit paper
26 papers, 867 citations indexed

About

Karolina Okła is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Karolina Okła has authored 26 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Karolina Okła's work include Immune Cell Function and Interaction (8 papers), Immune cells in cancer (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Karolina Okła is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Immune cells in cancer (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Karolina Okła collaborates with scholars based in Poland, United States and Finland. Karolina Okła's co-authors include Marcin Bobiński, Anna Wawruszak, Weiping Zou, Donna L. Färber, Willem Jan van Weelden, Andrea Romano, Johanna M.A. Pijnenborg, Jan Kotarski, Iwona Wertel and Arkadiusz Czerwonka and has published in prestigious journals such as The Journal of Experimental Medicine, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Karolina Okła

25 papers receiving 856 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms

2019 243 citations Marcin Bobiński, Karolina Okła et al. profile →

Peers

Karolina Okła

ONCOL

IMMUN

Marcin Bobiński Poland

Ming‐De Yan Taiwan

Huifang Shi China

Abdul Basit Baba India

Qiaoling Song China

Tao Xin China

Hua-Tao Wu China

Weixi Shen China

Giovanni Monego Italy

Junji Morimoto Japan

Marcin Bobiński Poland

Karolina Okła

108 ×0.3

ONCOL

120 ×0.4

IMMUN

87 ×0.3

196 ×1.0

47 ×0.7

Citations per year, relative to Karolina Okła Karolina Okła (= 1×) peers Marcin Bobiński

Countries citing papers authored by Karolina Okła

Since Specialization

Citations

This map shows the geographic impact of Karolina Okła's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karolina Okła with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karolina Okła more than expected).

Fields of papers citing papers by Karolina Okła

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karolina Okła. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karolina Okła. The network helps show where Karolina Okła may publish in the future.

Co-authorship network of co-authors of Karolina Okła

This figure shows the co-authorship network connecting the top 25 collaborators of Karolina Okła. A scholar is included among the top collaborators of Karolina Okła based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karolina Okła. Karolina Okła is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Małachowska, Beata, et al.. (2025). Therapy resistance: Modulating evolutionarily conserved heat shock protein machinery in cancer. Cancer Letters. 616. 217571–217571.

Pitter, Michael, Ilona Kryczek, Hongjuan Zhang, et al.. (2024). PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages. Cell Reports. 43(3). 113942–113942. 16 indexed citations

Okła, Karolina. (2023). Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward. Cells. 12(14). 1912–1912. 11 indexed citations

Czerwonka, Arkadiusz, et al.. (2023). Clinical Relevance of Mortalin in Ovarian Cancer Patients. Cells. 12(5). 701–701. 7 indexed citations

Ostrowska-Leśko, Marta, et al.. (2022). Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy. Frontiers in Immunology. 13. 1018256–1018256. 21 indexed citations

Okła, Karolina, Arkadiusz Czerwonka, Marcin Bobiński, et al.. (2020). Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1. Journal of Translational Medicine. 18(1). 220–220. 26 indexed citations

Bobiński, Marcin, Karolina Okła, Jarogniew J. Łuszczki, et al.. (2020). Gemcitabine and Selected mTOR Inhibitors in Uterine Sarcomas and Carcinosarcoma Cells- an Isobolographic Analysis. International Journal of Medical Sciences. 17(18). 2987–2997. 8 indexed citations

Wawruszak, Anna, Estera Okoń, Witold Jeleniewicz, et al.. (2019). <p>Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties</p>. Cancer Management and Research. Volume 11. 8345–8358. 17 indexed citations

Wawruszak, Anna, Joanna Kałafut, Estera Okoń, et al.. (2019). Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells. Cancers. 11(2). 148–148. 85 indexed citations

10.

Bobiński, Marcin, Karolina Okła, Wiesława Bednarek, et al.. (2019). The Effect of Fucoidan, a Potential New, Natural, Anti-Neoplastic Agent on Uterine Sarcomas and Carcinosarcoma Cell Lines: ENITEC Collaborative Study. Archivum Immunologiae et Therapiae Experimentalis. 67(2). 125–131. 19 indexed citations

11.

Wawruszak, Anna, Jarogniew J. Łuszczki, Joanna Kałafut, et al.. (2019). Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis. International Journal of Molecular Sciences. 20(15). 3663–3663. 17 indexed citations

12.

Bobiński, Marcin, Karolina Okła, Jarogniew J. Łuszczki, et al.. (2019). Isobolographic Analysis Demonstrates the Additive and Synergistic Effects of Gemcitabine Combined with Fucoidan in Uterine Sarcomas and Carcinosarcoma Cells. Cancers. 12(1). 107–107. 10 indexed citations

13.

Okła, Karolina, Arkadiusz Czerwonka, Anna Wawruszak, et al.. (2019). Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer. Frontiers in Immunology. 10. 691–691. 76 indexed citations

14.

Pawłowska, Anna, et al.. (2018). The role of selected populations of immune cells in the pathogenesis of endometriosis. 16(3). 167–176. 3 indexed citations

15.

Bobiński, Marcin, Karolina Okła, Jan Kotarski, et al.. (2018). Neuropilin 1 in uterine leiomyosarcoma. Clinical and pathological analysis. Ginekologia Polska. 89(1). 7–12. 6 indexed citations

16.

Okła, Karolina, Iwona Wertel, Anna Wawruszak, Marcin Bobiński, & Jan Kotarski. (2018). Blood-based analyses of cancer: Circulating myeloid-derived suppressor cells – is a new era coming?. Critical Reviews in Clinical Laboratory Sciences. 55(6). 376–407. 14 indexed citations

17.

Wertel, Iwona, et al.. (2017). Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells. Clinical & Translational Oncology. 19(12). 1489–1497. 9 indexed citations

18.

Wertel, Iwona, et al.. (2016). Assessment of regulatory Tcells, cytotoxic lymphocytes and dendritic cells in ovarian cancer patients before and after menopause.. Ginekologia Polska. 87(1). 11–18. 1 indexed citations

19.

Okła, Karolina, et al.. (2016). Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges. International Reviews of Immunology. 35(5). 372–385. 24 indexed citations

20.

Wawruszak, Anna, Arkadiusz Czerwonka, Karolina Okła, & Wojciech Rzeski. (2015). Anticancer effect of ethanol Lycium barbarum (Goji berry) extract on human breast cancer T47D cell line. Natural Product Research. 30(17). 1993–1996. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact